"Prevention is so much better than healing because it saves the labour of being sick." Thomas Adams, 1618"Prevention is so much better than healing because it saves the labour of being sick."
Thomas Adams, 1618

Prof. Little and Dr. Vaught join iPRI

Prof. Little and Dr. Vaught join iPRI

September 9, 2013

iPRI is delighted to announce that Prof. Little and Dr. Vaught join as Senior Research Fellows.

Julian Little, PhD holds a Canada Research Chair in Human Genome Epidemiology, and is a Professor in (and Chair of) the Department of Epidemiology and Community Medicine at the University of Ottawa. His PhD, from Aberdeen University, was on problems of ascertainment of congenital anomalies. Subsequently, he worked for the EUROCAT Central Registry in Brussels (Belgium), as a lecturer in epidemiology in Nottingham University, as an epidemiologist in the International Agency for Research on Cancer in Lyon, and as Professor of Epidemiology at Aberdeen University, during which he spent a sabbatical year at the Office of Genomics and Disease Prevention, CDC, Atlanta. His current research includes empirical work on potential biases in genetic association studies, harmonization of biobanks, the potential value of germline genetic profiling in prediction of risk for chronic disease, the potential value of information on family history in predicting risk for chronic disease, potential value of information on HPV and other factors in management of women with low-grade cervical abnormalities, and etiology of cleft lip and palate.

Jim Vaught spent 14 years at the U.S. National Cancer Institute (NCI), most recently as the Chief of the Biorepositories and Biospecimen Research Branch (BBRB) in the Cancer Diagnosis Program.  He earned a B.S. in chemistry from the University of Georgia and Ph.D. in biochemistry from the Medical College of Georgia. His additional training and research at Roswell Park Cancer Institute and the Michigan Cancer Foundation were in the areas of chemical carcinogenesis and drug metabolism. He has been working in the field of biorepository and biospecimen science for over 20 years. In 1999, he was one of the founding members of the International Society for Biological & Environmental Repositories (ISBER) and was its second president. He was involved in organizing and writing parts of the first edition of ISBER’s Best Practices for Repositories. In 2005, Dr. Vaught joined NCI BBRB and participated in the development of NCI’s Best Practices for Biospecimen Resources and the office’s other strategic initiatives.  Since 2005 he has served as the NIH representative to the Interagency Working Group on Scientific Collections, which was created by the Office of Science and Technology Policy. He serves on a number of biobank advisory groups including for the Telethon-Italy Genetic Biobank Network; the Stellenbosch University (Cape Town) H3-Africa Governance Advisory Panel; and the Biobanques Network (France) Scientific Board.  In addition to ISBER, Dr. Vaught is a member of the American Association for Cancer Research (AACR), the American Society for Pharmacology and Experimental Therapeutics, the European Society for Biopreservation & Biobanking and the American Association for Clinical Chemistry. He is the author of nearly 70 peer-reviewed articles and book chapters. From 2006 to 2012 he was Senior Editor for Biospecimens and Biorepositories for the AACR journal Cancer Epidemiology, Biomarkers and Prevention. In 2012 he became Editor-in-Chief of Biopreservation and Biobanking, the official journal of ISBER.  In 2013 Dr. Vaught was the recipient of ISBER’s award for Outstanding Achievement in Biobanking.

Latest News

Latest Posts

Quick Contact

Please enter your name.
Please enter a message.
Positive SSL